Rockwell Medical, Inc. (RMTI)
NASDAQ: RMTI · Real-Time Price · USD
0.7931
-0.0167 (-2.06%)
At close: May 22, 2026, 4:00 PM EDT
0.7713
-0.0218 (-2.75%)
After-hours: May 22, 2026, 7:30 PM EDT
Rockwell Medical Stock Forecast
Stock Price Forecast
According to 2 analysts polled by S&P Global, Rockwell Medical stock has a consensus rating of "Buy" and an average price target of $3.00. The average 1-year stock price forecast is 278.26% higher than the current stock price, while the lowest is $2.00 (+152.18%) and the highest is $4.00 (+404.35%).
Price Target: $3.00 (+278.26%)
Analyst Consensus: Buy
* Price targets were last updated on Mar 30, 2026.
Analyst Ratings
The average analyst rating for Rockwell Medical stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 1 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 1 | 1 | 1 | 1 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $2.5 → $2 | Strong Buy | Maintains | $2.5 → $2 | +152.18% | Mar 30, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $2.5 | Strong Buy | Reiterates | $2.5 | +215.22% | Jan 26, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $3 → $2.5 | Strong Buy | Maintains | $3 → $2.5 | +215.22% | Nov 13, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $7 → $3 | Strong Buy | Maintains | $7 → $3 | +278.26% | Mar 24, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $7 | Strong Buy | Reiterates | $7 | +782.61% | Dec 23, 2024 |
Financial Forecast
Revenue This Year
73.92M
from 69.26M
Increased by 6.73%
Revenue Next Year
81.59M
from 73.92M
Increased by 10.38%
EPS This Year
-0.08
from -0.15
EPS Next Year
-0.01
from -0.08
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 |
|---|---|---|
| High | 76.1M | 88.1M |
| Avg | 73.9M | 81.6M |
| Low | 71.0M | 74.6M |
Revenue Growth
| Revenue Growth | 2026 | 2027 |
|---|---|---|
| High | 9.9% | 19.1% |
| Avg | 6.7% | 10.4% |
| Low | 2.5% | 0.9% |
EPS Forecast
| EPS | 2026 | 2027 |
|---|---|---|
| High | -0.05 | 0.05 |
| Avg | -0.08 | -0.01 |
| Low | -0.10 | -0.06 |
EPS Growth
| EPS Growth | 2026 | 2027 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.